You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Rhode Island Department of Health has granted Immunovia, Inc., the US subsidiary of Immunovia, Clinical Laboratory licensure. The licensure allows physicians in Rhode Island to order the IMMray PanCan-d test for their patients. “Receiving licensure in Rhode Island now allows us to offer Already a subscriber Login You have…
Genmab has announced their financial results for the first quarter of 2016 including a rapid progress in the development of daratumumab with Janssen. Net Sales of DARZALEX (daratumumab) by Janssen for the first quarter of 2016 were USD 101.9 million, resulting in royalty income of DKK 83 millionAlready a subscriber Login…
AstraZeneca has made a successful move to Cambridge, UK, with the ‘topping out’ of its new strategic R&D centre and global corporate headquarters at the heart of the Cambridge Biomedical Campus (CBC). The company, including its biologics research and development arm, MedImmune, already haAlready a subscriber Login You have read…
Nasdaq Stockholm’s Listing Committee has approved the admission of Cantargia AB’s shares for trading on the main market of Nasdaq Stockholm and the first day of trading is scheduled for 25 September. The approval is subject to customary conditions, including the approval and registration of Already a subscriber Login You have…
